NL8302863A - Nieuwe tetrazinederivaten. - Google Patents
Nieuwe tetrazinederivaten. Download PDFInfo
- Publication number
- NL8302863A NL8302863A NL8302863A NL8302863A NL8302863A NL 8302863 A NL8302863 A NL 8302863A NL 8302863 A NL8302863 A NL 8302863A NL 8302863 A NL8302863 A NL 8302863A NL 8302863 A NL8302863 A NL 8302863A
- Authority
- NL
- Netherlands
- Prior art keywords
- group
- optionally substituted
- solution
- carbon atoms
- substituted phenyl
- Prior art date
Links
- 150000004905 tetrazines Chemical class 0.000 title claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 51
- -1 hy droxy Chemical group 0.000 claims description 38
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 31
- 125000004432 carbon atom Chemical group C* 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- 125000003342 alkenyl group Chemical group 0.000 claims description 15
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 13
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 12
- 125000001424 substituent group Chemical group 0.000 claims description 11
- 229910052717 sulfur Inorganic materials 0.000 claims description 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 7
- 125000000623 heterocyclic group Chemical group 0.000 claims description 7
- 125000004434 sulfur atom Chemical group 0.000 claims description 7
- 125000000304 alkynyl group Chemical group 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 3
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 4
- 241001331845 Equus asinus x caballus Species 0.000 claims 1
- 125000005236 alkanoylamino group Chemical group 0.000 claims 1
- 125000005055 alkyl alkoxy group Chemical group 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 150000002823 nitrates Chemical class 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical class CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 237
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 149
- 239000000243 solution Substances 0.000 description 128
- 239000000203 mixture Substances 0.000 description 106
- 239000007787 solid Substances 0.000 description 93
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 74
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 64
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 61
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 52
- 238000000354 decomposition reaction Methods 0.000 description 44
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 42
- 238000000921 elemental analysis Methods 0.000 description 40
- 239000000460 chlorine Substances 0.000 description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 30
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 28
- BCMYXYHEMGPZJN-UHFFFAOYSA-N 1-chloro-2-isocyanatoethane Chemical compound ClCCN=C=O BCMYXYHEMGPZJN-UHFFFAOYSA-N 0.000 description 21
- 235000010288 sodium nitrite Nutrition 0.000 description 21
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 20
- 239000003208 petroleum Substances 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical class CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- 238000004587 chromatography analysis Methods 0.000 description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 14
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 14
- 235000019341 magnesium sulphate Nutrition 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 239000013078 crystal Substances 0.000 description 13
- 239000000284 extract Substances 0.000 description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- 239000000741 silica gel Substances 0.000 description 12
- 229910002027 silica gel Inorganic materials 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 11
- 229910052739 hydrogen Inorganic materials 0.000 description 11
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 11
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 10
- 229960000583 acetic acid Drugs 0.000 description 10
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 10
- 239000000706 filtrate Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 238000004440 column chromatography Methods 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 6
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 229940124530 sulfonamide Drugs 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 5
- 229910000564 Raney nickel Inorganic materials 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 238000007911 parenteral administration Methods 0.000 description 5
- 239000008247 solid mixture Substances 0.000 description 5
- 150000003456 sulfonamides Chemical class 0.000 description 5
- FJKXXVLRHNIFOT-UHFFFAOYSA-N 1h-1,2,3,5-tetrazin-6-one Chemical compound O=C1N=CN=NN1 FJKXXVLRHNIFOT-UHFFFAOYSA-N 0.000 description 4
- DXVWMLQMDGMWEQ-UHFFFAOYSA-N 1h-imidazo[5,1-d][1,2,3,5]tetrazin-4-one Chemical compound O=C1NN=NC2=CN=CN12 DXVWMLQMDGMWEQ-UHFFFAOYSA-N 0.000 description 4
- VIRWKAJWTKAIMA-UHFFFAOYSA-N 2-chloroethyl acetate Chemical compound CC(=O)OCCCl VIRWKAJWTKAIMA-UHFFFAOYSA-N 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 239000003701 inert diluent Substances 0.000 description 4
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 4
- 229940075930 picrate Drugs 0.000 description 4
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- KQHHAYJVMXDMHI-UHFFFAOYSA-N 2-methyl-4-nitro-1h-imidazole-5-sulfonyl chloride Chemical compound CC1=NC([N+]([O-])=O)=C(S(Cl)(=O)=O)N1 KQHHAYJVMXDMHI-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000006978 adaptation Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- IDPURXSQCKYKIJ-UHFFFAOYSA-N 1-(4-methoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 2
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 2
- FFYTTYVSDVWNMY-UHFFFAOYSA-N 2-Methyl-5-nitroimidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1 FFYTTYVSDVWNMY-UHFFFAOYSA-N 0.000 description 2
- JRWAUKYINYWSTA-UHFFFAOYSA-N 2-amino-2-cyanoacetamide Chemical compound N#CC(N)C(N)=O JRWAUKYINYWSTA-UHFFFAOYSA-N 0.000 description 2
- FPJOCIZOSGXPGL-UHFFFAOYSA-N 2-butyl-5-diazoimidazole-4-carboxamide Chemical compound C(CCC)C1=NC(C(=N1)C(=O)N)=[N+]=[N-] FPJOCIZOSGXPGL-UHFFFAOYSA-N 0.000 description 2
- CINPESGJDJJVKV-UHFFFAOYSA-N 3-(2-chloroethyl)-6-methyl-8-propylsulfonylimidazo[5,1-d][1,2,3,5]tetrazin-4-one Chemical compound ClCCN1N=NC=2N(C1=O)C(=NC2S(=O)(=O)CCC)C CINPESGJDJJVKV-UHFFFAOYSA-N 0.000 description 2
- WARGTDKANSDREC-UHFFFAOYSA-N 4-amino-N,N,2-trimethyl-1H-imidazole-5-sulfonamide Chemical compound NC1=C(N=C(N1)C)S(N(C)C)(=O)=O WARGTDKANSDREC-UHFFFAOYSA-N 0.000 description 2
- HQQOOAOVOVCGGM-UHFFFAOYSA-N 4-diazo-2-methyl-5-methylsulfonylimidazole Chemical compound CC1=NC(=[N+]=[N-])C(S(C)(=O)=O)=N1 HQQOOAOVOVCGGM-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- RBYLRHFFJUGSNT-UHFFFAOYSA-N Cl.NC1=C(N=C(N1)C)S(=O)(=O)C Chemical compound Cl.NC1=C(N=C(N1)C)S(=O)(=O)C RBYLRHFFJUGSNT-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- BXDZOYLPNAIDOC-UHFFFAOYSA-N N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]-1-[2-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethyl]piperidine-4-carboxamide Chemical compound CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCN(CC(=O)NCCOCCOCCOCCNc4cccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c45)CC3)s2)o1 BXDZOYLPNAIDOC-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- UENWRTRMUIOCKN-UHFFFAOYSA-N benzyl thiol Chemical compound SCC1=CC=CC=C1 UENWRTRMUIOCKN-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000002027 dichloromethane extract Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000006396 nitration reaction Methods 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- CQRBGSZZSKJPCU-UHFFFAOYSA-N (4-amino-1h-imidazol-5-yl)-piperidin-1-ylmethanone;hydrochloride Chemical compound Cl.N1=CNC(C(=O)N2CCCCC2)=C1N CQRBGSZZSKJPCU-UHFFFAOYSA-N 0.000 description 1
- COWZNYTZVVEEKO-UHFFFAOYSA-N (4-methoxyphenyl)methylazanium;chloride Chemical compound Cl.COC1=CC=C(CN)C=C1 COWZNYTZVVEEKO-UHFFFAOYSA-N 0.000 description 1
- LNYABGRNNIGOSW-UHFFFAOYSA-N (5-diazonioimidazol-4-ylidene)-piperidin-1-ylmethanolate Chemical compound N\1=CN=C([N+]#N)C/1=C(/[O-])N1CCCCC1 LNYABGRNNIGOSW-UHFFFAOYSA-N 0.000 description 1
- VBWBRZHAGLZNST-UHFFFAOYSA-N 1,3-bis(2-chloroethyl)urea Chemical compound ClCCNC(=O)NCCCl VBWBRZHAGLZNST-UHFFFAOYSA-N 0.000 description 1
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- OZOZNHYGWJIUFA-UHFFFAOYSA-N 1h-imidazol-2-yl(piperidin-1-yl)methanone Chemical compound N=1C=CNC=1C(=O)N1CCCCC1 OZOZNHYGWJIUFA-UHFFFAOYSA-N 0.000 description 1
- OLKQIWCQICCYQS-UHFFFAOYSA-N 2-(4-methoxyphenyl)acetamide Chemical compound COC1=CC=C(CC(N)=O)C=C1 OLKQIWCQICCYQS-UHFFFAOYSA-N 0.000 description 1
- IRQOUOKEBHPMNA-UHFFFAOYSA-N 2-benzyl-5-diazoimidazole-4-carboxamide Chemical compound C(C1=CC=CC=C1)C1=NC(C(=N1)C(=O)N)=[N+]=[N-] IRQOUOKEBHPMNA-UHFFFAOYSA-N 0.000 description 1
- CYDGFAUMTFGKNG-UHFFFAOYSA-N 2-cyclohexyl-5-diazoimidazole-4-carboxamide Chemical compound C1(CCCCC1)C1=NC(C(=N1)C(=O)N)=[N+]=[N-] CYDGFAUMTFGKNG-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 229940093475 2-ethoxyethanol Drugs 0.000 description 1
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 description 1
- HTFZKMQGPPHEDI-UHFFFAOYSA-N 2-methyl-1h-imidazole-5-sulfonamide Chemical compound CC1=NC=C(S(N)(=O)=O)N1 HTFZKMQGPPHEDI-UHFFFAOYSA-N 0.000 description 1
- YTOWBJZYCMGYKV-UHFFFAOYSA-N 2-methyl-4-methylsulfanyl-5-nitro-1H-imidazole Chemical compound CC=1NC(=C(N1)SC)[N+](=O)[O-] YTOWBJZYCMGYKV-UHFFFAOYSA-N 0.000 description 1
- NLLFQCABKXCNNS-UHFFFAOYSA-N 2-methyl-4-methylsulfonyl-5-nitro-1H-imidazole Chemical compound CC=1NC(=C(N1)S(=O)(=O)C)[N+](=O)[O-] NLLFQCABKXCNNS-UHFFFAOYSA-N 0.000 description 1
- YMLKKXFCRGEYCU-UHFFFAOYSA-N 2-methyl-5-nitro-1h-imidazole-4-thiol Chemical compound CC1=NC(S)=C([N+]([O-])=O)N1 YMLKKXFCRGEYCU-UHFFFAOYSA-N 0.000 description 1
- YZEUHQHUFTYLPH-UHFFFAOYSA-N 2-nitroimidazole Chemical compound [O-][N+](=O)C1=NC=CN1 YZEUHQHUFTYLPH-UHFFFAOYSA-N 0.000 description 1
- HVIVTDWEJAOKKR-UHFFFAOYSA-N 3-(2-chloroethyl)-4-oxo-6-(2-phenylethyl)imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide Chemical compound N1=NN(CCCl)C(=O)N2C1=C(C(=O)N)N=C2CCC1=CC=CC=C1 HVIVTDWEJAOKKR-UHFFFAOYSA-N 0.000 description 1
- OXLCXBVBLSAUJO-UHFFFAOYSA-N 3-(2-chloroethyl)-4-oxo-6-propan-2-ylimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide Chemical compound N1=NN(CCCl)C(=O)N2C(C(C)C)=NC(C(N)=O)=C21 OXLCXBVBLSAUJO-UHFFFAOYSA-N 0.000 description 1
- KPZNLXONVJUBFG-UHFFFAOYSA-N 3-(2-chloroethyl)-4-oxo-6-propylimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide Chemical compound N1=NN(CCCl)C(=O)N2C(CCC)=NC(C(N)=O)=C21 KPZNLXONVJUBFG-UHFFFAOYSA-N 0.000 description 1
- MTTANBKQUNTRGF-UHFFFAOYSA-N 3-(2-chloroethyl)-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide Chemical compound N1=NN(CCCl)C(=O)N2C1=C(S(=O)(=O)N)N=C2 MTTANBKQUNTRGF-UHFFFAOYSA-N 0.000 description 1
- SUOPRBPCOYLDNC-UHFFFAOYSA-N 3-(2-chloroethyl)-6-ethyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide Chemical compound N1=NN(CCCl)C(=O)N2C(CC)=NC(C(N)=O)=C21 SUOPRBPCOYLDNC-UHFFFAOYSA-N 0.000 description 1
- MMSMNBAMEBSIKH-UHFFFAOYSA-N 3-(2-chloroethyl)-6-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide Chemical compound N1=NN(CCCl)C(=O)N2C(C)=NC(C(N)=O)=C21 MMSMNBAMEBSIKH-UHFFFAOYSA-N 0.000 description 1
- ZADSVILBOFLJFF-UHFFFAOYSA-N 3-(2-chloroethyl)-6-methyl-8-methylsulfinylimidazo[5,1-d][1,2,3,5]tetrazin-4-one Chemical compound ClCCN1N=NC=2N(C1=O)C(=NC2S(=O)C)C ZADSVILBOFLJFF-UHFFFAOYSA-N 0.000 description 1
- CGUOOAJNXYGEFB-UHFFFAOYSA-N 3-(2-chloroethyl)-8-(piperidine-1-carbonyl)imidazo[5,1-d][1,2,3,5]tetrazin-4-one Chemical compound N1=CN2C(=O)N(CCCl)N=NC2=C1C(=O)N1CCCCC1 CGUOOAJNXYGEFB-UHFFFAOYSA-N 0.000 description 1
- CAHWKRMIWNDLCP-UHFFFAOYSA-N 3-(2-chloroethyl)-8-ethylsulfonyl-6-methylimidazo[5,1-d][1,2,3,5]tetrazin-4-one Chemical compound ClCCN1N=NC=2N(C1=O)C(=NC2S(=O)(=O)CC)C CAHWKRMIWNDLCP-UHFFFAOYSA-N 0.000 description 1
- TVYRKSKMTZTXSN-UHFFFAOYSA-N 3-(2-chloroethyl)-n,n-dimethyl-4-oxopyrazolo[5,1-d][1,2,3,5]tetrazine-8-carboxamide Chemical compound N1=NN(CCCl)C(=O)N2C1=C(C(=O)N(C)C)C=N2 TVYRKSKMTZTXSN-UHFFFAOYSA-N 0.000 description 1
- BQSJKVZIMIYYKM-UHFFFAOYSA-N 3-diazopyrazole-4-carboxamide Chemical compound NC(=O)C1=CN=NC1=[N+]=[N-] BQSJKVZIMIYYKM-UHFFFAOYSA-N 0.000 description 1
- ACRWYXSKEHUQDB-UHFFFAOYSA-N 3-phenylpropionitrile Chemical compound N#CCCC1=CC=CC=C1 ACRWYXSKEHUQDB-UHFFFAOYSA-N 0.000 description 1
- LCMWOYNNYAVVLN-UHFFFAOYSA-N 4-amino-2-(2-phenylethyl)-1H-imidazole-5-carboxamide hydrochloride Chemical compound Cl.NC1=C(N=C(N1)CCC1=CC=CC=C1)C(=O)N LCMWOYNNYAVVLN-UHFFFAOYSA-N 0.000 description 1
- TZZMCWKXXZEYTP-UHFFFAOYSA-N 4-amino-N-[(4-methoxyphenyl)methyl]-2-methyl-1H-imidazole-5-sulfonamide hydrochloride Chemical compound Cl.NC1=C(N=C(N1)C)S(NCC1=CC=C(C=C1)OC)(=O)=O TZZMCWKXXZEYTP-UHFFFAOYSA-N 0.000 description 1
- WZNLIHBAMSARDC-UHFFFAOYSA-N 4-diazo-5-methylsulfonylimidazole Chemical compound CS(=O)(=O)C1=NC=NC1=[N+]=[N-] WZNLIHBAMSARDC-UHFFFAOYSA-N 0.000 description 1
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- YOJYWZSEUWUYAQ-UHFFFAOYSA-N 5-bromo-2-methyl-4-nitro-1h-imidazole Chemical compound CC1=NC([N+]([O-])=O)=C(Br)N1 YOJYWZSEUWUYAQ-UHFFFAOYSA-N 0.000 description 1
- MQEHZOJKAFDDIW-UHFFFAOYSA-N 5-diazo-2-(2-phenylethyl)imidazole-4-carboxamide Chemical compound [N+](=[N-])=C1C(=NC(=N1)CCC1=CC=CC=C1)C(=O)N MQEHZOJKAFDDIW-UHFFFAOYSA-N 0.000 description 1
- LXKYNXDRSSBLME-UHFFFAOYSA-N 5-diazo-2-methylimidazole-4-carboxamide Chemical compound [N+](=[N-])=C1C(=NC(=N1)C)C(=O)N LXKYNXDRSSBLME-UHFFFAOYSA-N 0.000 description 1
- RREVXGBSLCCEKT-UHFFFAOYSA-N 5-diazo-N,N,2-trimethylimidazole-4-sulfonamide Chemical compound [N+](=[N-])=C1C(=NC(=N1)C)S(N(C)C)(=O)=O RREVXGBSLCCEKT-UHFFFAOYSA-N 0.000 description 1
- ZVUJYAKERVHTIT-UHFFFAOYSA-N 5-methylsulfonyl-1H-imidazol-4-amine hydrochloride Chemical compound Cl.NC1=C(N=CN1)S(=O)(=O)C ZVUJYAKERVHTIT-UHFFFAOYSA-N 0.000 description 1
- VXCSKHCSXFSTLW-UHFFFAOYSA-N 5-nitro-1h-imidazole-4-thiol Chemical compound [O-][N+](=O)C=1NC=NC=1S VXCSKHCSXFSTLW-UHFFFAOYSA-N 0.000 description 1
- VYDWQPKRHOGLPA-UHFFFAOYSA-N 5-nitroimidazole Chemical compound [O-][N+](=O)C1=CN=CN1 VYDWQPKRHOGLPA-UHFFFAOYSA-N 0.000 description 1
- SBKFUIRJCGCFNK-UHFFFAOYSA-N 6-benzyl-3-(2-chloroethyl)-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide Chemical compound N1=NN(CCCl)C(=O)N2C1=C(C(=O)N)N=C2CC1=CC=CC=C1 SBKFUIRJCGCFNK-UHFFFAOYSA-N 0.000 description 1
- WZHKRFWJGSQIJA-UHFFFAOYSA-N 6h-1,2,4-triazin-5-one Chemical compound O=C1CN=NC=N1 WZHKRFWJGSQIJA-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OMXDDDQAIGTSIS-UHFFFAOYSA-N C1=CC=C(C=C1)CC2=NC(=[N+]=[N-])C=N2 Chemical compound C1=CC=C(C=C1)CC2=NC(=[N+]=[N-])C=N2 OMXDDDQAIGTSIS-UHFFFAOYSA-N 0.000 description 1
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 101100260565 Dictyostelium discoideum thyA gene Proteins 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000001382 Experimental Melanoma Diseases 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000005045 Interdigitating dendritic cell sarcoma Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000007093 Leukemia L1210 Diseases 0.000 description 1
- 208000006552 Lewis Lung Carcinoma Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- LGGOLGCFPMWJMY-UHFFFAOYSA-N N,2-diphenylacetamide hydrochloride Chemical compound Cl.O=C(CC1=CC=CC=C1)NC1=CC=CC=C1 LGGOLGCFPMWJMY-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical class CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- JJXOGOFEAOOLAZ-UHFFFAOYSA-N N-[(4-methoxyphenyl)methyl]-2-methyl-5-nitro-1H-imidazole-4-sulfonamide Chemical compound COC1=CC=C(CNS(=O)(=O)C=2N=C(NC2[N+](=O)[O-])C)C=C1 JJXOGOFEAOOLAZ-UHFFFAOYSA-N 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- MTTMQNRTNWVSCY-UHFFFAOYSA-N [N+](=[N-])=C1C(=NC(=N1)C(C)C)C(=O)N Chemical compound [N+](=[N-])=C1C(=NC(=N1)C(C)C)C(=O)N MTTMQNRTNWVSCY-UHFFFAOYSA-N 0.000 description 1
- XIIGKLBOPMNKRT-UHFFFAOYSA-N [N+](=[N-])=C1C(=NC(=N1)CC)C(=O)N Chemical compound [N+](=[N-])=C1C(=NC(=N1)CC)C(=O)N XIIGKLBOPMNKRT-UHFFFAOYSA-N 0.000 description 1
- AOXBCWSUKKUDEW-UHFFFAOYSA-N [N+](=[N-])=C1C(=NC(=N1)CCC)C(=O)N Chemical compound [N+](=[N-])=C1C(=NC(=N1)CCC)C(=O)N AOXBCWSUKKUDEW-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 229960003116 amyl nitrite Drugs 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000008049 diazo compounds Chemical class 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical compound Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000009957 hemming Methods 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- QWXYZCJEXYQNEI-OSZHWHEXSA-N intermediate I Chemical compound COC(=O)[C@@]1(C=O)[C@H]2CC=[N+](C\C2=C\C)CCc2c1[nH]c1ccccc21 QWXYZCJEXYQNEI-OSZHWHEXSA-N 0.000 description 1
- 239000011872 intimate mixture Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 1
- APVPOHHVBBYQAV-UHFFFAOYSA-N n-(4-aminophenyl)sulfonyloctadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 APVPOHHVBBYQAV-UHFFFAOYSA-N 0.000 description 1
- CSDTZUBPSYWZDX-UHFFFAOYSA-N n-pentyl nitrite Chemical compound CCCCCON=O CSDTZUBPSYWZDX-UHFFFAOYSA-N 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008016 pharmaceutical coating Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 208000029922 reticulum cell sarcoma Diseases 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 101150068774 thyX gene Proteins 0.000 description 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8223580 | 1982-08-17 | ||
| GB8223580 | 1982-08-17 | ||
| GB8223583 | 1982-08-17 | ||
| GB8223583 | 1982-08-17 | ||
| GB8226169 | 1982-09-14 | ||
| GB8226169 | 1982-09-14 | ||
| GB838306904A GB8306904D0 (en) | 1983-03-14 | 1983-03-14 | Compositions of matter |
| GB8306904 | 1983-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8302863A true NL8302863A (nl) | 1984-03-16 |
Family
ID=27449377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8302863A NL8302863A (nl) | 1982-08-17 | 1983-08-15 | Nieuwe tetrazinederivaten. |
Country Status (18)
| Country | Link |
|---|---|
| AU (1) | AU575782B2 (de) |
| BE (1) | BE897548A (de) |
| CA (1) | CA1254563A (de) |
| CH (1) | CH657855A5 (de) |
| DE (1) | DE3329505A1 (de) |
| DK (1) | DK374983A (de) |
| ES (1) | ES524995A0 (de) |
| FI (1) | FI80273C (de) |
| FR (1) | FR2531958B1 (de) |
| GR (1) | GR78688B (de) |
| HU (1) | HU189321B (de) |
| IE (1) | IE55849B1 (de) |
| IL (1) | IL69500A (de) |
| IT (1) | IT1194375B (de) |
| LU (1) | LU84969A1 (de) |
| NL (1) | NL8302863A (de) |
| NZ (1) | NZ205272A (de) |
| SE (1) | SE455198B (de) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2932305A1 (de) * | 1979-08-09 | 1981-02-26 | Basf Ag | Azolo- eckige klammer auf 5,1-d eckige klammer zu - eckige klammer auf 1,2,3,5 eckige klammer zu -tetrazin-4-one und verfahren zur herstellung dieser verbindungen |
| OA07174A (fr) * | 1981-08-24 | 1984-04-30 | May & Baker Ltd | Nouvelles imidazotétrazionones, leur préparation et les médicaments qui les contiennent. |
-
1983
- 1983-08-12 FR FR8313246A patent/FR2531958B1/fr not_active Expired
- 1983-08-12 GR GR72210A patent/GR78688B/el unknown
- 1983-08-15 IE IE1913/83A patent/IE55849B1/xx unknown
- 1983-08-15 NL NL8302863A patent/NL8302863A/nl not_active Application Discontinuation
- 1983-08-15 HU HU832860A patent/HU189321B/hu unknown
- 1983-08-15 IL IL69500A patent/IL69500A/xx unknown
- 1983-08-15 CA CA000434582A patent/CA1254563A/en not_active Expired
- 1983-08-15 FI FI832927A patent/FI80273C/fi not_active IP Right Cessation
- 1983-08-15 AU AU17968/83A patent/AU575782B2/en not_active Ceased
- 1983-08-15 NZ NZ205272A patent/NZ205272A/en unknown
- 1983-08-15 SE SE8304415A patent/SE455198B/sv not_active IP Right Cessation
- 1983-08-16 DE DE3329505A patent/DE3329505A1/de not_active Withdrawn
- 1983-08-16 IT IT22566/83A patent/IT1194375B/it active
- 1983-08-16 DK DK374983A patent/DK374983A/da not_active Application Discontinuation
- 1983-08-16 LU LU84969A patent/LU84969A1/fr unknown
- 1983-08-17 ES ES83524995A patent/ES524995A0/es active Granted
- 1983-08-17 CH CH4490/83A patent/CH657855A5/fr not_active IP Right Cessation
- 1983-08-17 BE BE0/211366A patent/BE897548A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK374983D0 (da) | 1983-08-16 |
| FR2531958A1 (fr) | 1984-02-24 |
| NZ205272A (en) | 1986-12-05 |
| SE8304415D0 (sv) | 1983-08-15 |
| IE831913L (en) | 1984-02-17 |
| FR2531958B1 (fr) | 1986-10-31 |
| GR78688B (de) | 1984-09-27 |
| CA1254563A (en) | 1989-05-23 |
| FI832927A (fi) | 1984-02-18 |
| SE8304415L (sv) | 1984-02-18 |
| FI832927A0 (fi) | 1983-08-15 |
| DE3329505A1 (de) | 1984-02-23 |
| FI80273B (fi) | 1990-01-31 |
| DK374983A (da) | 1984-02-18 |
| IT1194375B (it) | 1988-09-22 |
| BE897548A (fr) | 1984-02-17 |
| LU84969A1 (fr) | 1984-03-23 |
| IL69500A (en) | 1989-01-31 |
| ES8502441A1 (es) | 1985-01-01 |
| SE455198B (sv) | 1988-06-27 |
| IE55849B1 (en) | 1991-01-30 |
| CH657855A5 (fr) | 1986-09-30 |
| IT8322566A0 (it) | 1983-08-16 |
| AU1796883A (en) | 1984-02-23 |
| ES524995A0 (es) | 1985-01-01 |
| HU189321B (en) | 1986-06-30 |
| AU575782B2 (en) | 1988-08-11 |
| FI80273C (fi) | 1990-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5260291A (en) | Tetrazine derivatives | |
| US4438128A (en) | Cardioactive aryloxypropanolamines | |
| FI73434B (fi) | Foerfarande foer framstaellning av /3h/-imidazo-/5,1-d/-1,2,3,5-tetrazin-4-onderivat med terapeutisk verkan. | |
| DE4019892A1 (de) | Neue xanthinderivate | |
| KR20030013475A (ko) | 항암제로서의 치환된 트리아졸로피리미딘 | |
| EP0370236B1 (de) | Indolocarbazol-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel | |
| CA2019812C (en) | Novel 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of aids | |
| GB2125402A (en) | New tetrazine derivatives | |
| NL8302863A (nl) | Nieuwe tetrazinederivaten. | |
| US3234217A (en) | Pyrazole carboxylic acid hydrazides | |
| Attanasi et al. | Study of reactions between 1, 2-diaza-1, 3-butadienes and N, N′-diaryl-or N, N′-dialkylthioureas | |
| Davis et al. | Synthesis of substituted 2, 1-benzisothiazoles | |
| El-Ablack | Synthesis of some new benzimidazole derivatives of pharmaceutical interest | |
| EP2740727B1 (de) | Chinazolinanaloga zur Verwendung als Antikrampfmittel | |
| EP1200439B1 (de) | 1,2-dihydro-1-oxo-pyrazino[1,2-]indolederivate | |
| NL8002120A (nl) | Nieuwe benzo-as-triazinederivaten en werkwijze voor de bereiding van deze verbindingen. | |
| EP2592085B1 (de) | Thiazolo[3,2-a][1,3]diazepin-Derivate und diese enthaltende pharmazeutische Zusammensetzungen als Antikonvulsiva und Verfahren zu ihrer Herstellung | |
| AU8554098A (en) | New 2,3-benzodiazepine derivatives | |
| Pilgram et al. | Synthesis of 1‐aryl‐3‐trifluoromethyl‐5‐methylthio‐1, 2, 4‐triazoles from 2‐arylmethylisothiosemicarbazides and 1, 1, 1‐trichloro‐3, 3, 3‐trifluoroacetone | |
| RU2763732C1 (ru) | Применение (R*)-3-(4-Хлорбензоил)-2-гидрокси-3а-((R*)-2-оксоиндолин-3-ил)-5-фенилпирроло[1,2-a]хиноксалин-1,4(3аH,5H)-диона в качестве средства, обладающего противомикробной активностью | |
| CH622517A5 (en) | Process for the preparation of 6-phenyl-4H-s-triazolo-[4,3-a][1,4]benzodiazepine and 4,5-dihydro-7-phenyl-s-triazolo- [4,3-a][1,5]benzodiazocines | |
| Nguyen et al. | Synthesis and bioevaluation of some new N-substituted pyranophenothiazines | |
| EP0711275B1 (de) | (thio)carbamidinsäure-derivate und diese enthaltende arzneimittel | |
| HU203554B (en) | Process for producing 5-amino-8-(phenyl- or substituted phenyl)-3h, 6h-1,4,5a, 8a- - tetraaza-acenaphtylen-3-ones and pharmaceutical compositions containing them | |
| EP0174833A2 (de) | Triazolochinolin-Derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BT | A notification was added to the application dossier and made available to the public | ||
| A85 | Still pending on 85-01-01 | ||
| BT | A notification was added to the application dossier and made available to the public | ||
| BV | The patent application has lapsed |